Integration and Reorganization of Group Companies and Establishment of a Consolidated Management Structure
First written in FY2016. 27 of 31 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-07.
90 other companies' latest entry also says "Advanced".
- 2026-08-07AdvancedEarnings
「SHIP HEALTHCARE PHARMACY Co., Ltd., a consolidated subsidiary, absorbed and merged DELPHIA Co., Ltd., which had also been a consolidated subsidiary.」
A merger by absorption between consolidated subsidiaries was completed in the pharmacy business, advancing group restructuring. - FY2026AdvancedAnnual report
「キングラン㈱ merged with キングラン・メディケア㈱, キングラン九州㈱, キングラン北海道㈱, and キングラン関西㈱; シップヘルスケアファーマシー㈱, renamed from シップヘルスケアファーマシー東日本㈱, merged with 日星調剤㈱, グリーンファーマシー㈱, ㈲スターシップ, ㈱ＭＯＮＡＫＡ, and ㈱オーエムピー, which had not been a consolidated subsidiary in the previous consolidated fiscal year; and シップヘルスケアフード㈱ merged with グラン・グルメ㈱, respectively, through absorption-type mergers.」
Reorganizations involving mergers between subsidiaries and corporate name changes were completed in the Kingrun, dispensing pharmacy, and food services businesses, advancing the integration of the group management structure. - FY2026-H1AdvancedAnnual report
「キングラン㈱ merged with キングラン・メディケア㈱, キングラン九州㈱, キングラン北海道㈱, and キングラン関西㈱; シップヘルスケアファーマシー㈱, renamed from シップヘルスケアファーマシー東日本㈱, merged with 日星調剤㈱, グリーンファーマシー㈱, ㈲スターシップ, ㈱ＭＯＮＡＫＡ, and ㈱オーエムピー, which had not been a consolidated subsidiary in the previous consolidated fiscal year; and シップヘルスケアフード㈱ merged with グラン・グルメ㈱, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
Absorption-type mergers between consolidated subsidiaries were completed in the Kingrun, dispensing pharmacy, and food services businesses, advancing the integration and reorganization of the group companies in practical terms. - FY2025AdvancedAnnual report
「シップヘルスケアファーマシー東日本㈱ merged with ㈲Ｃ.Ｍ.Ｊ and ㈲フレンズ, ㈱ハートライフ merged with 中嶋メディカルサプライ㈱ and オーラムメディカル㈱, ㈱SMC merged with ㈲オルガンメディカル, ㈱トム・メディック, and ㈱エヌジェイメディカル, and グリーンライフ㈱ merged with グリーンライフ東日本㈱ and ㈱オールケアー, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
Several absorption-type mergers between consolidated subsidiaries were completed, advancing the establishment of a consolidated management structure and the integration and reorganization of the group companies in practical terms. - FY2025-H1AdvancedAnnual report
「During the current interim consolidated accounting period, シップヘルスケアファーマシー東日本㈱, a consolidated subsidiary, absorbed ㈲Ｃ.Ｍ.Ｊ and ㈲フレンズ, which had also been consolidated subsidiaries. In addition, ㈱ＭＯＮＡＫＡ was included in the scope of consolidation following the acquisition of its shares.」
In addition to an absorption-type merger between consolidated subsidiaries, shares in ＭＯＮＡＫＡ were acquired and the company was consolidated, advancing the integration and reorganization of the group companies and the implementation of consolidated management. - FY2024-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary ㈱サンライフ merged with ティック㈱, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈱エヌジェイメディカル was included in the scope of consolidation following the newly acquired shares.」
An absorption-type merger between consolidated subsidiaries was completed, and shares in ㈱エヌジェイメディカル were acquired and the company was consolidated, advancing changes in group reorganization and the scope of consolidated management. - FY2024-Q2Changes in the scope of consolidated management through mergers between consolidated subsidiaries and new acquisitionsAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with ㈲菜の花薬局, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈲Ｃ.Ｍ.Ｊ and ㈲フレンズ were included in the scope of consolidation following the newly acquired shares.」
In addition to an absorption-type merger between consolidated subsidiaries, shares in Ｃ.Ｍ.Ｊ and フレンズ were acquired and the companies were consolidated, changing the scope of group reorganization and consolidated management. - FY2024-Q1Removal from consolidation following the transfer of all shares in a consolidated subsidiaryAnnual report
「During the first quarter of the consolidated fiscal year, all shares in ㈱セントラルユニコリア, which had been a consolidated subsidiary of the Company, were transferred, and the company was removed from the scope of consolidation.」
All shares in a consolidated subsidiary were transferred and the company was removed from the scope of consolidation, changing the scope covered by group integration and reorganization and consolidated management. - FY2023-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, ㈱オールケアー was included in the scope of consolidation following the newly acquired shares.」
Shares in ㈱オールケアー were acquired and the company was consolidated, further expanding the scope of group integration and reorganization and consolidated management. - FY2023-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, ㈱トム・メディック merged with ㈱ＨＤ－メディカルコミニュケーションズ, グリーンライフ㈱ merged with ㈱ハッピーケア, グリーンライフ東日本㈱ merged with ㈲寿老会, and グリーンアニマル㈱ merged with ㈱ｈａｎａ, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
4 absorption-type mergers between consolidated subsidiaries were completed, advancing the integration and reorganization of the group companies in practical terms. - FY2022AdvancedAnnual report
「The group consists of the Company, 56 consolidated subsidiaries, and 4 associates accounted for under the equity method, as of 31 March 2022,」
Following the consolidation of newly acquired companies, the addition of equity-method associates, and several mergers between consolidated subsidiaries, the number of consolidated subsidiaries increased from 55 to 56, expanding the scope of group reorganization and consolidated management. - FY2022-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with カインドネス㈲ and ㈲ケイツーファーマシー, which had also been consolidated subsidiaries, through an absorption-type merger.」
A new absorption-type merger was completed between consolidated subsidiaries related to the dispensing pharmacy business, advancing the integration and reorganization of the group companies. - FY2022-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary グリーンファーマシー㈱ merged with ㈱オオサカ薬局, which had also been a consolidated subsidiary, through an absorption-type merger.」
An additional absorption-type merger between consolidated subsidiaries was carried out in the dispensing pharmacy business, advancing the integration and reorganization of the group companies. - FY2022-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, ㈱エフエスユニマネジメント merged with ㈱チェーンマネジメント, ㈱SMC merged with メディカルツーリズム・ジャパン㈱, and シップヘルスケアファーマシー東日本㈱ merged with ㈱M'sファーマシー, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
3 absorption-type mergers between consolidated subsidiaries were completed, further advancing the integration and reorganization of the group companies. - FY2021RestatedAnnual report
「The group consists of the Company, 55 consolidated subsidiaries, and 4 associates accounted for under the equity method, as of 31 March 2021,」
The policy of reorganizing the group and managing it on a consolidated basis through absorption-type mergers between consolidated subsidiaries and new acquisitions has continued, bringing the number of consolidated subsidiaries to 55. - FY2021-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, 小西医療器㈱ merged with 小西共和ホールディング㈱ and 共和医理器㈱, while シップヘルスケアファーマシー東日本㈱ merged with ㈲ウィル・ウエイ and ㈱ふれあい, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
Absorption-type mergers involving medical equipment distributors and companies related to dispensing pharmacies were completed between consolidated subsidiaries, advancing group integration and reorganization. - FY2021-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, the consolidated subsidiary ㈱日本ネットワークサービス merged with ㈱アネット, which had also been a consolidated subsidiary, through an absorption-type merger.」
The consolidated subsidiary 日本ネットワークサービス completed an absorption-type merger with アネット, advancing the integration and reorganization of the group companies. - FY2020AdvancedAnnual report
「㈱Ｉ＆Ｃ, ㈱日本システム家具, ㈱ジョイアップ, ㈱日本ネットワークサービス and its subsidiary ㈱アネット, ㈱ふれあい, and ㈱Ｍ'ｓファーマシー have been included in the scope of consolidation from the current consolidated fiscal year because their shares were newly acquired.」
Multiple newly acquired companies were consolidated, bringing the number of consolidated subsidiaries to 53 as of 31 March 2020. The scope of group reorganization and consolidated management continues to expand. - FY2020-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, ㈱日本ネットワークサービス, its subsidiary ㈱アネット, and ㈱ふれあい were included in the scope of consolidation following the newly acquired shares.」
Shares in 日本ネットワークサービス, its subsidiary アネット, and ふれあい were acquired and the companies were consolidated, advancing group reorganization and the establishment of a consolidated management structure. - FY2020-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, ㈱日本システム家具 and ㈱ジョイアップ were included in the scope of consolidation following the newly acquired shares.」
Shares in 日本システム家具 and ジョイアップ were acquired and the companies were consolidated, advancing group reorganization and the establishment of a consolidated management structure. - FY2020-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with ㈲花梨薬局, which had also been a consolidated subsidiary, through an absorption-type merger.」
An absorption-type merger between consolidated subsidiaries was also carried out in the dispensing pharmacy business, advancing the reorganization of the group. - FY2019-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with ㈲なごみ薬局, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈲ウィル・ウエイ was included in the scope of consolidation following the newly acquired shares.」
In addition to an absorption-type merger between consolidated subsidiaries, shares in ウィル・ウエイ were acquired and the company was consolidated, advancing the implementation of group reorganization and consolidated management. - FY2019-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary ㈱エフエスユニ merged with ㈱ＡＭＣ, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, the consolidated subsidiary ㈱エフエスユニマネジメント merged with ㈱ヘルスケアリソースマネジメント, which had also been a consolidated subsidiary, through an absorption-type merger.」
2 absorption-type mergers between consolidated subsidiaries were completed, further advancing the integration and reorganization of the group companies. - FY2019-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with みどり調剤㈲, which had also been a consolidated subsidiary, through an absorption-type merger.」
An absorption-type merger between consolidated subsidiaries was completed, advancing the integration and reorganization of the group companies in the dispensing pharmacy business. - FY2018AdvancedAnnual report
「オーラムメディカル㈱ merged with ㈱TMA, 日本パナユーズ㈱ merged with 大阪パナユーズ㈱, and 小西医療器㈱ merged with ㈱野上器械店, respectively, through absorption-type mergers. These were all organizational reorganizations between consolidated subsidiaries.」
3 absorption-type mergers between consolidated subsidiaries were completed, advancing the integration and reorganization of the group companies. - FY2018-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary 小西医療器㈱ merged with ㈱野上器械店, which had also been a consolidated subsidiary, through an absorption-type merger, while the consolidated subsidiary 日本パナユーズ㈱ merged with 大阪パナユーズ㈱, which had also been a consolidated subsidiary, through an absorption-type merger.」
2 absorption-type mergers between consolidated subsidiaries were completed, further advancing the integration and reorganization of the group companies. - FY2018-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary オーラムメディカル㈱ merged with ㈱TMA, which had also been a consolidated subsidiary, through an absorption-type merger.」
An absorption-type merger between consolidated subsidiaries was completed, advancing the integration and reorganization of the group companies in practical terms. - FY2016First statedAnnual report
「We will review the business segments to optimize enterprise value, establish a consolidated management structure by segment, and build a new structure centered on the holding company.」
The review of business segments, segment-based management, and establishment of a holding company-centered structure are future priorities.